IMA vs ROL · rev $9.2M vs P/E 41, rev $3.39B
ImageneBio, Inc. (IMA) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
IMA currently screens at market cap $64.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the IMA and ROL stock pages for the full models.
Not investment advice.